帕里辛A通过AKT/mTOR信号通路抑制口腔状细胞癌
Lei Ma1, Zhibin Liu1, Eungyung Kim2
1Department of Animal Science and Biotechnology, Research Institute for Innovative Animal Science, Kyungpook National University, Daegu 37224, Republic of Korea.
Pharmaceuticals (Basel, Switzerland)
|October 26, 2024
概括
帕里辛A是一种天然化合物,有效地抑制了口腔状细胞癌 (OSCC) 的生长,迁移和入侵. 这项研究突出了Parishin A.
科学领域:
- 在瘤学瘤学.
- 自然产品 化学 化学
- 分子生物学分子生物学
背景情况:
- 口腔状细胞癌 (OSCC) 由于其具有攻击性和有限的治疗选择,因此具有重大治疗挑战.
- 帕里辛A是一种来自*Gastrodia elata*的化合物,具有多种治疗特性,但其在OSCC中的作用尚未被理解.
研究的目的:
- 调查帕里辛A对OSCC的抗癌作用.
- 阐明帕里辛A在OSCC中的作用的基础分子机制.
主要方法:
- 在OSCC细胞系中,使用不同度的Parishin A.进行了治疗.
- 细胞活力,殖民地形成,迁移和入侵分别使用CCK-8,阿加罗斯凝,伤口愈合和Matrigel试验进行了评估.
- PI3K/AKT/mTOR通路和上皮层-介质细胞转换 (EMT) 标记物的蛋白质表达被分析为西式斑点.
主要成果:
- 帕里辛A显著抑制OSCC细胞活力,殖民地形成,迁移和入侵以剂量依赖的方式,而不影响正常细胞.
- 巴里辛A治疗导致E-cadherin的增加和N-cadherin和vimentin的减少,表明EMT的抑制.
- 该化合物降低了PI3K,AKT和mTOR的酸化,这表明该关键信号通路的调节.
结论:
- 帕里辛A显示强大的抗癌活性对OSCC.
- 这些发现表明Parishin A作为口腔状细胞癌的潜在治疗剂具有前途.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K